These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1133 related items for PubMed ID: 24056623
1. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS. Transplantation; 2014 Jan 15; 97(1):71-7. PubMed ID: 24056623 [Abstract] [Full Text] [Related]
2. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y. J Am Coll Surg; 2015 Mar 15; 220(3):297-304.e3. PubMed ID: 25617912 [Abstract] [Full Text] [Related]
3. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Levy G, Greig PD, Renner EL, Grant DR. Liver Transpl; 2012 Mar 15; 18(3):315-22. PubMed ID: 22140013 [Abstract] [Full Text] [Related]
6. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liang W, Wu L, Ling X, Schroder PM, Ju W, Wang D, Shang Y, Kong Y, Guo Z, He X. Liver Transpl; 2012 Oct 15; 18(10):1226-36. PubMed ID: 22685095 [Abstract] [Full Text] [Related]
8. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results. Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L. Hepatogastroenterology; 2012 Oct 15; 59(114):505-10. PubMed ID: 22353516 [Abstract] [Full Text] [Related]
9. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Br J Surg; 2007 Jan 15; 94(1):78-86. PubMed ID: 17016793 [Abstract] [Full Text] [Related]
10. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival. Moon JI, Kwon CH, Joh JW, Choi GS, Jung GO, Kim JM, Shin M, Choi SJ, Kim SJ, Lee SK. Transplant Proc; 2012 Mar 15; 44(2):487-93. PubMed ID: 22410053 [Abstract] [Full Text] [Related]
11. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, Ichai P, Saliba F, Adam R, Castaing D, Azoulay D. Hepatology; 2011 May 15; 53(5):1570-9. PubMed ID: 21520172 [Abstract] [Full Text] [Related]
12. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio. Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y. Transplantation; 2013 Dec 15; 96(11):1008-12. PubMed ID: 24113512 [Abstract] [Full Text] [Related]
13. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy. Lei J, Yan L, Wang W. Eur J Gastroenterol Hepatol; 2013 Nov 15; 25(11):1340-6. PubMed ID: 23652915 [Abstract] [Full Text] [Related]
14. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation. Xiao GQ, Song JL, Shen S, Yang JY, Yan LN. World J Gastroenterol; 2014 Aug 21; 20(31):10953-9. PubMed ID: 25152599 [Abstract] [Full Text] [Related]
15. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ, Wei YG. Hepatobiliary Pancreat Dis Int; 2010 Aug 21; 9(4):366-9. PubMed ID: 20688599 [Abstract] [Full Text] [Related]
16. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver Transpl; 2005 Oct 21; 11(10):1265-72. PubMed ID: 16184545 [Abstract] [Full Text] [Related]
17. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma. Abdel-Wahab M, Sultan AM, Fathy OM, Salah T, Elshobary MM, Elghawalby NA, Yassen AM, Elsarraf WM, Elsaadany MF, Zalatah K. Hepatogastroenterology; 2013 Oct 21; 60(128):1847-53. PubMed ID: 24719918 [Abstract] [Full Text] [Related]
18. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up. Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS. Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468 [Abstract] [Full Text] [Related]
19. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA. Liver Transpl; 2009 Dec 27; 15(12):1861-6. PubMed ID: 19938113 [Abstract] [Full Text] [Related]